{"id":"W2008621188","doi":"10.1158/0008-5472.sabcs-09-201","title":"Sunitinib (SU) in Combination with Trastuzumab (T) for the Treatment of Advanced Breast Cancer (ABC): Activity and Safety Results from a Phase II Study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Taxane; Internal medicine; Breast cancer; Lapatinib; Sunitinib; Cancer; Neutropenia; Pharmacokinetics; Metastatic breast cancer; Dosing; Clinical endpoint; Trastuzumab; Pharmacology; Oncology; Gastroenterology; Clinical trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004216108,0.000207451,0.0004634358,0.0001754869,0.0002868061,0.00001787126,0.0001249743,0.00005572029,0.00005055744],"category_scores_gemma":[0.00004514466,0.0001315449,0.00004579344,0.0005522594,0.0002856519,0.0001684801,0.0000219159,0.0002446744,2.487876e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001112418,"about_ca_system_score_gemma":0.0004969799,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005285217,"about_ca_topic_score_gemma":0.004321747,"domain_scores_codex":[0.9981115,0.0001384709,0.0002944485,0.0004863593,0.0005386067,0.0004306322],"domain_scores_gemma":[0.9982535,0.0006255316,0.0001226029,0.0004315025,0.0004503301,0.0001165488],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1041763,0.004876246,0.001197947,0.00002711014,0.0001948991,0.0000142208,0.008186115,0.0001929478,0.02274383,0.00003121146,0.00001553427,0.8583437],"study_design_scores_gemma":[0.2215268,0.0522792,0.6644914,0.0009534355,0.0002563244,0.0000217097,0.01026213,0.0007649193,0.03903556,0.0004894658,0.009494362,0.0004246699],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850115,0.002288667,0.0001412233,0.007257513,0.00004484424,0.003805961,0.001375499,0.00002284781,0.00005193275],"genre_scores_gemma":[0.9961876,0.001979308,0.0001391351,0.00004428583,0.0001380834,0.0011907,0.00003965153,0.00002806805,0.0002531121],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.857919,"threshold_uncertainty_score":0.7989702,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06576479026102895,"score_gpt":0.4372951659954871,"score_spread":0.3715303757344581,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}